Prague, Czechia

Jiri Tauchman

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2021.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiri Tauchman: Innovator in Pharmaceutical Chemistry

Introduction

Jiri Tauchman is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing important chemical compounds. His work is particularly relevant in the context of developing treatments for serious diseases.

Latest Patents

Jiri Tauchman holds a patent for a process for the production of 2-chloro-4-nitroimidazole derivatives. This improved process is crucial for preparing these derivatives, which serve as useful intermediates in the formulation of an anti-tuberculosis drug. The method involves chlorinating nitroimidazoles using a chlorinating agent and an activating agent, resulting in the desired 2-chloro-4-nitroimidazole derivatives.

Career Highlights

Tauchman is currently associated with Otsuka Pharmaceutical Company, Limited, where he applies his expertise in pharmaceutical development. His innovative approach to chemical processes has positioned him as a valuable asset in the industry. With a focus on improving drug formulations, he continues to contribute to advancements in medical treatments.

Collaborations

Throughout his career, Jiri Tauchman has collaborated with esteemed colleagues such as Jan Koci and Petr Novak. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical innovations.

Conclusion

Jiri Tauchman exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the production of vital chemical compounds, underscore the importance of research in developing effective treatments for diseases. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…